Genetic Analysis AS (XSAT:GEAN)
Sweden
· Delayed Price · Currency is SEK · Price in NOK 0.675
-0.005 (-0.74%)
At close: Mar 9, 2026
Genetic Analysis AS Market Cap
Genetic Analysis AS has a market cap or net worth of 44.57 million as of March 10, 2026. Its market cap has increased by 76.76% in one year.
Market Cap
44.57M
Enterprise Value
27.72M
Revenue
19.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.68
Market Cap Chart
Since October 1, 2021, Genetic Analysis AS's market cap has decreased from 235.48M to 44.57M, a decrease of -81.07%. That is a compound annual growth rate of -31.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 45.00M | 1.61% |
| Dec 30, 2025 | 44.29M | 81.07% |
| Dec 30, 2024 | 24.46M | -31.37% |
| Dec 29, 2023 | 35.64M | -34.69% |
| Dec 30, 2022 | 54.57M | -66.71% |
| Dec 30, 2021 | 163.91M | -30.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Touchtech AB | 47.45M |
| Redsense Medical AB | 50.98M |
| Sound Dimension AB | 56.80M |
| Vidhance AB | 34.80M |
| Lightning Group AB | 31.36M |
| Monivent AB | 30.21M |
| QBNK Holding AB | 67.28M |
| BiBBInstruments AB | 73.33M |